Fact Sheet for Healthcare Providers: Emergency Use of the Prismaflex ST Set During the COVID-19 Pandemic | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: Emergency Use of the Prismaflex ST Set During the COVID-19 Pandemic

05/20/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 5/20/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Prismaflex ST Set to provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic. (PDF)